IL32 and metabolic dysfunction-associated steatotic liver disease: Baselli et al. highlighted the significance and the overexpression of the interleukin-32 gene in NAFLD patients, as well as its potential usefulness as a candidate biomarker and an NAFLD-related cytokine.